Roche Holding AG Share Price Swiss Exchange
Stocks
ROG
CH0012032048
Pharmaceuticals
OTC Markets Traded| Market Cap | 312B 381B 341B 285B 537B 35,782B 554B 3,761B 1,500B 19,092B 1,429B 1,398B 60,273B | P/E 2026 * |
21x | P/E 2027 * | 18.9x |
|---|---|---|---|---|---|
| Enterprise Value | 324B 395B 354B 296B 557B 37,126B 574B 3,902B 1,556B 19,810B 1,482B 1,451B 62,537B | EV / Sales 2026 * |
5.12x | EV / Sales 2027 * | 4.8x |
| Free-Float |
88.78% | Yield 2026 * |
2.57% | Yield 2027 * | 2.63% |
Last Transcript: Roche Holding AG
| 1 day | -1.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 14/03/2023 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 05/06/2011 |
| Chief Operating Officer | - | 30/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 31/12/1995 |
Severin Schwan
CHM | Chairman | 59 | 14/03/2023 |
| Director/Board Member | 73 | 02/03/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.35% | +2.01% | - | - | 384B | ||
| -0.79% | -4.48% | +44.44% | +127.49% | 1,216B | ||
| +1.43% | +1.11% | +47.73% | +82.08% | 656B | ||
| +1.07% | -1.21% | +32.99% | +106.31% | 509B | ||
| -0.36% | -2.84% | +47.23% | +64.51% | 384B | ||
| -0.14% | -1.87% | +71.05% | +40.63% | 362B | ||
| -0.78% | +0.59% | +31.01% | +59.68% | 311B | ||
| -0.80% | +6.73% | +11.89% | +35.64% | 293B | ||
| +0.03% | -1.20% | +45.89% | +68.76% | 249B | ||
| -0.41% | -2.22% | +35.24% | +105.68% | 208B | ||
| Average | -0.38% | +0.60% | +40.83% | +76.75% | 465.31B | |
| Weighted average by Cap. | -0.30% | +0.03% | +42.47% | +88.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.25B 77.16B 69.21B 57.74B 109B 7,254B 112B 762B 304B 3,870B 290B 283B 12,218B | 66.13B 80.68B 72.36B 60.37B 114B 7,584B 117B 797B 318B 4,047B 303B 296B 12,775B |
| Net income | 14.82B 18.08B 16.21B 13.53B 25.49B 1,699B 26.29B 179B 71.22B 907B 67.86B 66.4B 2,863B | 16.54B 20.18B 18.1B 15.1B 28.45B 1,897B 29.35B 199B 79.5B 1,012B 75.75B 74.12B 3,195B |
| Net Debt | 11.72B 14.3B 12.83B 10.7B 20.16B 1,344B 20.8B 141B 56.34B 717B 53.68B 52.53B 2,265B | 5.25B 6.41B 5.75B 4.79B 9.03B 602B 9.31B 63.29B 25.24B 321B 24.04B 23.53B 1,014B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

















